Report: Barbs traded between Care New England, Lifespan after failed deal

health earnings
The Boston Globe reported some tense exchanges between the presidents of Care New England and Lifespan. (Getty/turk_stock_photographer)

Relations have apparently soured between Rhode Island health systems Care New England and Lifespan after the collapse of a potential merger earlier this summer.

In June, a potential deal for Partners HealthCare to acquire Care New England (CNE)—Rhode Island's second-largest health system—was stymied following a request by Rhode Island's governor that the health system continue to explore efforts to create a "unified, local system" with state-based institutions Brown University and Lifespan.

But last week, the Boston Globe reportedly obtained letters documenting some tense exchanges between Care New England President and Chief Executive James E. Fanale, M.D., and Lifespan President and Chief Executive Timothy J. Babineau, M.D.

Innovation Awards

Submit your nominations for the FierceHealthcare Innovation Awards

The FierceHealthcare Innovation Awards showcases outstanding innovation that is driving improvements and transforming the industry. Our expert panel of judges will determine which companies demonstrate innovative solutions that have the greatest potential to save money, engage patients, or revolutionize the industry. Deadline for submissions is this Friday, October 18th.

According to a letter published by the Globe and dated July 25, Fanale said Lifespan abruptly terminated a case management program delivered by Care New England's accountable care organization Integra at a Lifespan hospital. Specifically, he said in the letter, Integra was informed its case managers would no longer be allowed to assist patients at Lifespan's Rhode Island Hospital.

"The timing of this decision seems coincident with and in retaliation to Care New England's recent decision to exit merger discussions," the letter reads.

RELATED: Partners HealthCare ends bid for Care New England health system

"Your accusation that the decision was retaliatory and related to the end of our negotiations is as offensive as it is absurd," the letter reads.

RELATED: Partners HealthCare ends bid for Care New England health system

Suggested Articles

As drugmakers face billions in legal settlements and judgments, we must keep our eye on what will truly defeat the opioid crisis.

As the public debate on health reform rolls on, a new report analyzes how these different approaches could impact insurers' bottom lines.

A House panel is going to consider several changes to Nancy Pelosi's drug prices plan, including stiff penalties for not being transparent.